AREVO Announces Strategic Investment and Technology Development Agreement with In-Q-Tel
Partnership will drive development of AREVOs Composite Additive Manufacturing Technology for the U.S. Intelligence Community
Santa Clara, Calif., June 1, 2017 -- AREVO Inc., a leader in composite additive manufacturing technology, today announced that it has closed a strategic investment and technology development agreement with In-Q-Tel (IQT), the non-profit strategic investor that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community.
AREVO has developed a new Additive Manufacturing (AM) solution for making ultra strong and lightweight composite parts to replace metal parts for production applications. AREVOs core technology relies on the unprecedented synergy between software, materials, composite additive process and robotics. Through breakthrough innovations in these technologies, AREVO is enabling on-demand manufacturing of mass-customized, lightweight 3D printed composite parts in high volume.
"Arevos additive manufacturing technology delivers complex parts with a unique value proposition which cannot be made with any conventional or other additive manufacturing techniques," said Katie Gray, Investments Partner at IQT." "Our partnership with Arevo will enable IQTs customers to stay ahead of the curve in developing new devices critical to our nations security."
"Partnering with IQT in this manner is a great vote of confidence in our design and composite manufacturing process methods," said Hemant Bheda, Chief Executive Officer and co-founder of AREVO. "We have made steady progress over the past year in defense applications and we believe our work with IQT will open more doors for us."
About AREVO
AREVO
About IQT
IQT is the non-profit strategic investor that accelerates the development and delivery of cutting-edge technologies to U.S. government agencies that keep our nation safe. IQT was established in 1999 with a distinct mission: to identify and partner with startup companies developing innovative technologies that protect and preserve our nations security. Visit www.iqt.org for more information.
Featured Product
Reduce Worker Discomfort with Industrial Sports Medicine™ Solution
Workers with musculoskeletal pain lose an average of 5.5 hours of productive time every week. But musculoskeletal injuries are avoidable with preventative care. Briotix Health's Industrial Sports Medicine™ solution is proven to increase employee productivity and reduce the occurrence and expense of musculoskeletal injuries. With a focus on early intervention, our Industrial Sports Medicine Professionals work in your facilities to manage discomforts and reduce injury risks for your employees. This best-in-class care is not only good for your bottom line by reducing lost workdays and absenteeism, but it also improves your employees' work experience in a meaningful way with personalized support to keep them performing their best. Learn More About Industrial Sports Medicine™ by Briotix Health